These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 2424090)

  • 1. Future perspectives for biological response modifiers: a viewpoint.
    Mihich E
    Semin Oncol; 1986 Jun; 13(2):234-54. PubMed ID: 2424090
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological response modifiers: their potential and limitations in cancer therapeutics.
    Mihich E
    Cancer Invest; 1985; 3(1):71-83. PubMed ID: 2578860
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological response modifiers: preclinical evaluation and clinical activity.
    Smalley RV; Oldham RK
    Crit Rev Oncol Hematol; 1984; 1(3):259-94. PubMed ID: 6085037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BRM in the treatment of cancer].
    Takaku F
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1597-602. PubMed ID: 2454612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologicals and biological response modifiers: new approaches to cancer treatment.
    Oldham RK
    Cancer Invest; 1985; 3(1):53-70. PubMed ID: 3918773
    [No Abstract]   [Full Text] [Related]  

  • 6. Approaches to cancer therapy using biological response modifiers.
    MacEwen EG
    Vet Clin North Am Small Anim Pract; 1985 May; 15(3):667-88. PubMed ID: 2409659
    [No Abstract]   [Full Text] [Related]  

  • 7. Biologicals and biological response modifiers: fourth modality of cancer treatment.
    Oldham RK
    Cancer Treat Rep; 1984 Jan; 68(1):221-32. PubMed ID: 6198081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of melanoma treatment with interferon, cytokines and other biologic response modifiers in Japan.
    Ishihara K; Hayasaka K; Yamazaki N
    J Invest Dermatol; 1989 May; 92(5 Suppl):326S-328s. PubMed ID: 2469742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological Response Modifiers Programme and cancer chemotherapy.
    Oldham RK
    Int J Tissue React; 1982; 4(3):173-88. PubMed ID: 6183193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antineoplastic mechanism of immunotherapy in neoplastic cells].
    Ogura T; Hosoe S
    Nihon Rinsho; 1986 Feb; 44(2):403-10. PubMed ID: 3517418
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytokines and monoclonal antibodies. Immunologic approaches to tumor therapy].
    Pfreundschuh M
    Fortschr Med; 1986 Dec; 104(47-48):973-6. PubMed ID: 2434398
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphokines, monoclonal antibodies, and other biological response modifiers in the treatment of cancer.
    Oldham RK; Thurman GB; Talmadge JE; Stevenson HC; Foon KA
    Cancer; 1984 Dec; 54(11 Suppl):2795-806. PubMed ID: 6437660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic aspects of gynecologic cancer.
    Di Saia PJ
    Obstet Gynecol Surv; 1985 Mar; 40(3):111-35. PubMed ID: 2579358
    [No Abstract]   [Full Text] [Related]  

  • 14. Manipulation of host resistance in cancer therapy.
    Baldwin RW
    Springer Semin Immunopathol; 1982; 5(2):113-25. PubMed ID: 6755781
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of biological response modifiers on effector cells with cytotoxic activity against tumors.
    Herberman RB
    Semin Oncol; 1986 Jun; 13(2):195-9. PubMed ID: 2424088
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biological immunomodulators in the treatment of cancer].
    Bello C; Richard C; Hermosa V; Iriondo A; Muruzábal MJ; Pérez Encinas M; Zubizarreta A
    Sangre (Barc); 1988 Apr; 33(2):132-43. PubMed ID: 2456623
    [No Abstract]   [Full Text] [Related]  

  • 17. Biologic response modifiers in the therapy of metastatic renal cell carcinoma.
    Quesada JR
    Semin Oncol; 1988 Aug; 15(4):396-407. PubMed ID: 2457256
    [No Abstract]   [Full Text] [Related]  

  • 18. [BRM (biological response modifiers) and radiation].
    Goto M; Okawa T
    Rinsho Hoshasen; 1987 Jul; 32(7):847-8. PubMed ID: 2446026
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunotherapy].
    Urushizaki I; Niizu Y
    Gan No Rinsho; 1986 Aug; 32(10):1100-4. PubMed ID: 2431168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotherapy: the fourth modality of cancer treatment.
    Oldham RK
    J Cell Physiol Suppl; 1986; 4():91-9. PubMed ID: 2427531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.